COMPASS Cardio-Oncology Multidisciplinary Patient ASsistance Solution
- Coordinator
- King's College London, United Kingdom
- Runs
- 1 March 2026 to 28 February 2031
- Status
- Running
- EU funding
- €28.7m
- Total cost
- €49.8m
- Partners
- 64 organisations in 22 countries
- Type
- Research and Innovation Action
- Grant agreement
- 101253264
What the project is doing
In the project's own words, from its summary on CORDIS.
The rise in cardiovascular disease among cancer patients and survivors, due to treatment side effects, poses a significant challenge to patient outcomes and healthcare systems. Managing cardiotoxicity is difficult due to its delayed onset and lack of reliable biomarkers, often requiring dose reduction or discontinuation of cancer treatment, which may compromise its effectiveness. The COMPASS project aims to optimize cardiovascular health for cancer patients and survivors through a comprehensive, patient-centered clinical pathway over five years.
It will advance cardio-oncology research by creating an international network and developing tools for better disease prediction, prevention, diagnosis, and management. The project focuses on integrating cardio-oncology care pathways, optimizing diagnostic biomarkers, and utilizing AI-supported imaging and wearable technologies for early detection and personalized treatment, while promoting sustainable healthcare delivery and reducing environmental impact.
COMPASS methodology includes three pillars: (i) Discovery of Novel Biomarkers and Parameters, (ii) AI Prediction Models and Clinical Decision Support System, and (iii) Improving Care Delivery and Patient Engagement. Activities across the program include Health Economics, Communication, Dissemination, Exploitation and Sustainability, and Ethics and Regulatory Aspects. This public private partnership of 51 academic and industrial partners will collaborate to translate scientific advancements into clinical applications, apply novel AI approaches, ensuring solutions are effective, meet patient needs, and align with European health policies and regulations.
Key stakeholders include clinicians, nurses, patients, payers, regulators, and industry actors. COMPASS aims to advance cardio-oncology research, reduce healthcare costs, and improve patient well-being through innovative tools, collaborative networks, and policy support. Ultimately, it aims to improve patient outcomes for both cancer and heart health.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| King's College London | London | United Kingdom | Coordinator |
| Ge Healthcare Austria GmbH & Co Og | Pfaffing | Austria | Third party |
| Association Hospitaliere De Bruxelles-Centre Hospitalier Universitaire Jules Bordet | Anderlecht | Belgium | Participant |
| Cliniques Universitaires Saint-Luc ASBL | Bruxelles / Brussel | Belgium | Third party |
| Hict | Gent | Belgium | Participant |
| Katholieke Universiteit Leuven | Leuven | Belgium | Participant |
| Themi Consulting BV | Gent | Belgium | Participant |
| Universite Catholique De Louvain | Louvain La Neuve | Belgium | Participant |
| Arma Biosciences Inc. | Calgary | Canada | Participant |
| Aktiia SA | Neuchatel | Switzerland | Participant |
| Csem Centre Suisse D'electronique Et De Microtechnique SA - Recherche Et Developpement | Neuchatel | Switzerland | Participant |
| F. Hoffmann-La Roche AG | Basel | Switzerland | Participant |
| Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eV | Munchen | Germany | Participant |
| Ge Healthcare GmbH | Dusseldorf | Germany | Third party |
| Helmholtz Zentrum Muenchen Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt GmbH | Neuherberg | Germany | Participant |
| Spear UG (haftungsbeschrankt) | München | Germany | Participant |
| Universitatsklinikum Heidelberg | Heidelberg | Germany | Participant |
| Aarhus Universitet | Aarhus C | Denmark | Participant |
| Ge Healthcare Danmark A/s | Herlev | Denmark | Third party |
| Bridg Ou | Tallin | Estonia | Participant |
| Keemilise Ja Bioloogilise Fuusika Instituut | Tallinn | Estonia | Participant |
| Ethniko Kentro Erevnas Kai Technologikis Anaptyxis | Thermi Thessaloniki | Greece | Participant |
| Atrys Health SA | Madrid | Spain | Participant |
| Centro Nacional De Investigaciones Cardiovasculares Carlos Iii (f.s.p.) | Madrid | Spain | Participant |
| ECG Médica S.L. | Valencia | Spain | Participant |
| Fundacio De Recerca Clinic Barcelona-Institut D Investigacions Biomediques August Pi I Sunyer | Barcelona | Spain | Participant |
| Fundacion Centro De Tecnologias De Interaccion Visual Y Comunicaciones Vicomtech | Donostia San Sebastian | Spain | Participant |
| Fundacion Espanola De Oncologia Radioterapica | Madrid | Spain | Participant |
| Fundacion Para La Investigacion Biomedica Del Hospital Gregorio Maranon | Madrid | Spain | Third party |
| Fundacion Para La Investigacion Biomedica Del Hospital Universiatrio La Paz | Madrid | Spain | Third party |
| Hospital Clinic De Barcelona | Barcelona | Spain | Third party |
| Medtronic Iberica SA | Madrid | Spain | Participant |
| Multiverse Computing SL | San Sebastian | Spain | Participant |
| Servicio Madrileno De Salud | Madrid | Spain | Participant |
| Universidad De Navarra | Pamplona | Spain | Participant |
| Zabala Innovation Consulting SA | Mutilva Alta Navarra | Spain | Participant |
| Ge Healthcare Finland Oy | Helsinki | Finland | Third party |
| Ge Medical Systems Scs | Buc | France | Third party |
| Gustave Roussy Transfert | Villejuif | France | Third party |
| Institut Gustave Roussy | Villejuif | France | Participant |
| Unicancer | Paris | France | Participant |
| Ge Healthcare Magyarorszag Kft | Budapest | Hungary | Participant |
| Genomate Health Hungary Kft | Budapest | Hungary | Participant |
| Syreon Kutato Intezet Korlatolt Felelossegu Tarsasag | Budapest | Hungary | Participant |
| Észak-Pesti Centrumkórház - Honvédkórház | Budapest | Hungary | Participant |
| Global Heart Hub Company Limited by Guarantee | Galway | Ireland | Participant |
| Ge Medical Systems Israel Ltd | Haifa | Israel | Third party |
| Datawizard SRL | Roma | Italy | Participant |
| Fondazione Policlinico Universitario Agostino Gemelli Irccs | Roma | Italy | Participant |
| Universita Della Calabria | Arcavacata Di Rende | Italy | Participant |
| Academisch Ziekenhuis Leiden | Leiden | Netherlands | Participant |
| Fwdfaster Ai Research BV | Utrecht | Netherlands | Participant |
| Stichting Amsterdam Umc | Amsterdam | Netherlands | Participant |
| Ge Vingmed Ultrasound AS | Horten | Norway | Third party |
| Norges Teknisk-Naturvitenskapelige Universitet NTNU | Trondheim | Norway | Participant |
| Universidade Do Porto | Porto | Portugal | Participant |
| Iaroca AB | Domsten | Sweden | Participant |
| Turkiye Bilimsel Ve Teknolojik Arastirma Kurumu | Ankara | Türkiye | Participant |
| Ge Medical Systems Limited | Chalfont St Giles | United Kingdom | Third party |
| Guys and St Thomas' Nhs Foundationtrust | London | United Kingdom | Participant |
And 4 more organisations. Full list on CORDIS.
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI